Clinical Trial Update: A Phase IV, Prospective, Observational, Open Label, Single Centre Cohort Trial to be Conducted in Norway During One Year to Assess the Cumulative Pregnancy Rate in a New Series of In-vitro Fertilization (IVF) Treatment Cycles Following Three or More Previous IVF Treatment Cycles Without Live Birth

View source ↗

Summary

Phase IV observational study conducted in Norway to assess cumulative pregnancy rates in IVF cycles after three or more prior IVF treatments without live birth.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Infertility | Status: COMPLETED